Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Apr;75(4):577–582. doi: 10.1136/jnnp.2003.020529

The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis

J Greenhalgh 1, H Ford 1, A Long 1, K Hurst 1
PMCID: PMC1739024  PMID: 15026500

Abstract

Objectives: This study aimed to develop further a diary originally devised to measure the impact of multiple sclerosis (MS) as part of a cost utility study of beta interferon, and to evaluate its reliability, validity, and responsiveness in an outpatient sample of people with MS.

Methods: The original diary was further developed using qualitative and quantitative methods to ensure that it addressed the views of people with MS. The psychometric properties of the MS Symptom and Impact Diary (MSSID) were evaluated in a sample of 77 people who completed the MSSID daily for 12 weeks. Internal and test–retest reliability, discriminant and convergent validity, and responsiveness were assessed using traditional psychometric methods.

Results: The MSSID formed three, internally consistent scales that measured mobility, fatigue, and the overall impact of MS. The test–retest reliability of the mobility scale was adequate for individual comparisons (ICC>0.90) and the fatigue and overall impact scales were adequate for group comparisons (ICC>0.70). The MSSID was able to distinguish between clinical groups depending on clinical course, indoor ambulation status, and relapse status. It demonstrated associations with other single point instruments in the expected direction. Compared with single point instruments, its responsiveness was similar or better, especially in detecting short term improvements in functioning.

Conclusions: The MSSID may provide a useful complement to currently available instruments to measure the outcomes of MS within clinical trials. Further research is needed to explore its feasibility in the context of a randomised controlled trial and its utility for clinicians.

Full Text

The Full Text of this article is available as a PDF (238.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker L. M. Sense making in multiple sclerosis: the information needs of people during an acute exacerbation. Qual Health Res. 1998 Jan;8(1):106–120. doi: 10.1177/104973239800800108. [DOI] [PubMed] [Google Scholar]
  2. Barraquer-Bordas L., Giménez-Roldán S. Idiopathic torsion dystonia as described by Barraquer-Roviralta. Adv Neurol. 1988;50:665–666. [PubMed] [Google Scholar]
  3. Barraquer Ll. Lluís Barraquer Roviralta, fundador de la neurología clínica española. El nacimiento de una escuela. Neurologia. 2002 Jan;17(1):33–39. [PubMed] [Google Scholar]
  4. Bressman S. B., de Leon D., Kramer P. L., Ozelius L. J., Brin M. F., Greene P. E., Fahn S., Breakefield X. O., Risch N. J. Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann Neurol. 1994 Nov;36(5):771–777. doi: 10.1002/ana.410360514. [DOI] [PubMed] [Google Scholar]
  5. Cheng E. M., Hays R. D., Myers L. W., Ellison G. W., Beckstrand M., Vickrey B. G. Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores. Mult Scler. 2001 Dec;7(6):405–410. doi: 10.1177/135245850100700610. [DOI] [PubMed] [Google Scholar]
  6. Devinsky O. Outcome research in neurology: incorporating health-related quality of life. Ann Neurol. 1995 Feb;37(2):141–142. doi: 10.1002/ana.410370202. [DOI] [PubMed] [Google Scholar]
  7. Fayers P. MRC quality of life studies using a daily diary card--practical lessons learned from cancer trials. Qual Life Res. 1995 Aug;4(4):343–352. doi: 10.1007/BF01593887. [DOI] [PubMed] [Google Scholar]
  8. Fletcher N. A., Harding A. E., Marsden C. D. Intrafamilial correlation in idiopathic torsion dystonia. Mov Disord. 1991;6(4):310–314. doi: 10.1002/mds.870060407. [DOI] [PubMed] [Google Scholar]
  9. Ford H. L., Gerry E., Johnson M. H., Tennant A. Health status and quality of life of people with multiple sclerosis. Disabil Rehabil. 2001 Aug 15;23(12):516–521. doi: 10.1080/09638280010022090. [DOI] [PubMed] [Google Scholar]
  10. Ford H. L., Gerry E., Tennant A., Whalley D., Haigh R., Johnson M. H. Developing a disease-specific quality of life measure for people with multiple sclerosis. Clin Rehabil. 2001 Jun;15(3):247–258. doi: 10.1191/026921501673658108. [DOI] [PubMed] [Google Scholar]
  11. Freeman J. A., Hobart J. C., Thompson A. J. Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology. 2001 Jul 10;57(1):68–74. doi: 10.1212/wnl.57.1.68. [DOI] [PubMed] [Google Scholar]
  12. Greenhalgh J., Long A. F., Brettle A. J., Grant M. J. Reviewing and selecting outcome measures for use in routine practice. J Eval Clin Pract. 1998 Nov;4(4):339–350. doi: 10.1111/j.1365-2753.1998.tb00097.x. [DOI] [PubMed] [Google Scholar]
  13. Harwood R. H., Rogers A., Dickinson E., Ebrahim S. Measuring handicap: the London Handicap Scale, a new outcome measure for chronic disease. Qual Health Care. 1994 Mar;3(1):11–16. doi: 10.1136/qshc.3.1.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hobart J., Lamping D., Fitzpatrick R., Riazi A., Thompson A. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain. 2001 May;124(Pt 5):962–973. doi: 10.1093/brain/124.5.962. [DOI] [PubMed] [Google Scholar]
  15. Hoogervorst E. L. J., Eikelenboom M. J., Uitdehaag B. M. J., Polman C. H. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439–442. doi: 10.1136/jnnp.74.4.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Juniper E. F., O'Byrne P. M., Ferrie P. J., King D. R., Roberts J. N. Measuring asthma control. Clinic questionnaire or daily diary? Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1330–1334. doi: 10.1164/ajrccm.162.4.9912138. [DOI] [PubMed] [Google Scholar]
  17. Kazis L. E., Anderson J. J., Meenan R. F. Effect sizes for interpreting changes in health status. Med Care. 1989 Mar;27(3 Suppl):S178–S189. doi: 10.1097/00005650-198903001-00015. [DOI] [PubMed] [Google Scholar]
  18. Koopman W., Schweitzer A. The journey to multiple sclerosis: a qualitative study. J Neurosci Nurs. 1999 Feb;31(1):17–26. doi: 10.1097/01376517-199902000-00003. [DOI] [PubMed] [Google Scholar]
  19. Kroencke D. C., Denney D. R., Lynch S. G. Depression during exacerbations in multiple sclerosis: the importance of uncertainty. Mult Scler. 2001 Aug;7(4):237–242. doi: 10.1177/135245850100700405. [DOI] [PubMed] [Google Scholar]
  20. Liu C., Blumhardt L. D. Assessing relapses in treatment trials of relapsing and remitting multiple sclerosis: can we do better? Mult Scler. 1999 Feb;5(1):22–28. doi: 10.1177/135245859900500105. [DOI] [PubMed] [Google Scholar]
  21. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miller C. M. The lived experience of relapsing multiple sclerosis: a phenomenological study. J Neurosci Nurs. 1997 Oct;29(5):294–304. [PubMed] [Google Scholar]
  23. Nelson L. M., Franklin G. M., Hamman R. F., Boteler D. L., Baum H. M., Burks J. S. Referral bias in multiple sclerosis research. J Clin Epidemiol. 1988;41(2):187–192. doi: 10.1016/0895-4356(88)90093-5. [DOI] [PubMed] [Google Scholar]
  24. Nortvedt M. W., Riise T., Myhr K. M., Nyland H. I., Hanestad B. R. Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a. Mult Scler. 1999 Oct;5(5):317–322. doi: 10.1177/135245859900500503. [DOI] [PubMed] [Google Scholar]
  25. Parkin D., Jacoby A., McNamee P., Miller P., Thomas S., Bates D. Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):144–149. doi: 10.1136/jnnp.68.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Riazi A., Hobart J. C., Lamping D. L., Fitzpatrick R., Thompson A. J. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry. 2002 Dec;73(6):701–704. doi: 10.1136/jnnp.73.6.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rothwell P. M., McDowell Z., Wong C. K., Dorman P. J. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 May 31;314(7094):1580–1583. doi: 10.1136/bmj.314.7094.1580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rothwell P. M. Quality of life in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998 Oct;65(4):433–433. doi: 10.1136/jnnp.65.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Sandha G. S., Hunt R. H., Veldhuyzen van Zanten S. J. A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia. Scand J Gastroenterol. 1999 Mar;34(3):244–249. doi: 10.1080/00365529950173636. [DOI] [PubMed] [Google Scholar]
  30. Verbrugge L. M., Balaban D. J. Patterns of change in disability and well-being. Med Care. 1989 Mar;27(3 Suppl):S128–S147. doi: 10.1097/00005650-198903001-00011. [DOI] [PubMed] [Google Scholar]
  31. Verbrugge L. M. Health diaries. Med Care. 1980 Jan;18(1):73–95. doi: 10.1097/00005650-198001000-00006. [DOI] [PubMed] [Google Scholar]
  32. Vickrey B. G., Hays R. D., Harooni R., Myers L. W., Ellison G. W. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995 Jun;4(3):187–206. doi: 10.1007/BF02260859. [DOI] [PubMed] [Google Scholar]
  33. Wood-Dauphinee S. L., Opzoomer M. A., Williams J. I., Marchand B., Spitzer W. O. Assessment of global function: The Reintegration to Normal Living Index. Arch Phys Med Rehabil. 1988 Aug;69(8):583–590. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Web-only Appendix]
jnnpsyc_75_4_577__index.html (1.3KB, html)
jnnpsyc_75_4_577__1.pdf (53.5KB, pdf)
[Web-only appendix]
jnnpsyc_75_4_577_v2_index.html (1.2KB, html)
jnnpsyc_75_4_577_v2_1.pdf (53.5KB, pdf)

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES